Inspire Investing, LLC Neurocrine Biosciences Inc Transaction History

Inspire Investing, LLC

$858 Million
Q4 2024

A detailed history of Inspire Investing, LLC transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, Inspire Investing, LLC holds 1,889 shares of NBIX stock, worth $231,629. This represents 0.03% of its overall portfolio holdings.

Number of Shares

1,889

Previous 2,469 23.49%

Holding current value

$231,629

Previous $284,000 9.51%

% of portfolio

0.03%

Previous 0.03%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Jan 17, 2025	SELL	$111.62 - $139.44 $64,739 - $80,875	-580 Reduced 23.49%	1,889 $257,000
Q3 2024 Oct 10, 2024	SELL	$114.58 - $153.15 $235,347 - $314,570	-2,054 Reduced 45.41%	2,469 $284,000
Q2 2024 Aug 12, 2024	SELL	$130.86 - $143.19 $1.02 Million - $1.11 Million	-7,773 Reduced 63.22%	4,523 $622,000
Q1 2024 May 07, 2024	BUY	$130.4 - $143.74 $788,268 - $868,908	6,045 Added 96.7%	12,296 $1.7 Million
Q4 2023 Feb 12, 2024	SELL	$106.07 - $132.76 $556,549 - $696,591	-5,247 Reduced 45.63%	6,251 $823,000
Q3 2023 Oct 26, 2023	SELL	$94.02 - $117.1 $989,654 - $1.23 Million	-10,526 Reduced 47.79%	11,498 $1.29 Million
Q2 2023 Jul 31, 2023	BUY	$89.53 - $104.87 $115,225 - $134,967	1,287 Added 6.21%	22,024 $2.08 Million
Q1 2023 Apr 24, 2023	BUY	$94.11 - $123.02 $497,089 - $649,791	5,282 Added 34.18%	20,737 $2.1 Million
Q4 2022 Jan 26, 2023	BUY	$106.72 - $127.06 $1.44 Million - $1.72 Million	13,506 Added 692.97%	15,455 $0
Q3 2022 Nov 07, 2022	BUY	$92.03 - $107.81 $179,366 - $210,121	1,949 New	1,949 $207,000
Q2 2020 Aug 12, 2020	SELL	$85.09 - $130.36 $6,466 - $9,907	-76 Closed	0 $0
Q1 2020 May 08, 2020	BUY	$75.11 - $113.76 $5,708 - $8,645	76 New	76 $7,000
Q1 2018 Apr 13, 2018	SELL	$75.88 - $92.43 $531 - $647	-7 Closed	0 $0
Q4 2017 Feb 15, 2018	BUY	$58.53 - $77.59 $409 - $543	7	7 $1,000

Others Institutions Holding NBIX

# of Institutions

642

Shares Held

94.3M

Call Options Held

632K

Put Options Held

621K

View Full List

About NEUROCRINE BIOSCIENCES INC

Ticker NBIX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 95,639,296
Market Cap $11.7B
Description
Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...

More about NBIX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Inspire Investing, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Inspire Investing, LLC with notifications on news.

Account

Inspire Investing, LLC Neurocrine Biosciences Inc Transaction History